made with patients
3 Results found

University of Maryland, Baltimore, Dept. Pharmaceutical Health Se...

M-CERSI Conference on Patient-Focused Drug Development

Asset 1

Uppsala University

PREFER- IMI

Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) is a five year public-private research project where academic researchers and the pharmaceutical...

Asset 3

Swansea University

UK MS Register

There are three parts to the UK MS Register- 1. Participant portal- anyone who has been diagnosed with MS is asked to fill in a patient outcome measures questionnaire which has b...

Asset 2
Add Initiative